HeartSciences (HSCS) Research & Development (2021 - 2026)
HeartSciences (HSCS) posted quarterly Research & Development of $476205.0 for Q2 2026, down 48.75% year-on-year from $929091.0 in Q2 2025, and down 34.5% on a QoQ basis from $727026.0 in Q4 2025.
HeartSciences (HSCS) Research & Development (2021 - 2026) Analysis & Trends
HeartSciences (HSCS) has reported Research & Development for 6 consecutive years, with $476205.0 the latest figure, recorded in Q2 2026.
- Quarterly Research & Development fell 48.75% year-over-year to $476205.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $3.1 million (down 28.65% YoY) and the FY2026 annual result came in at $2.8 million, down 35.27% from the prior year.
- Research & Development fell to $476205.0 in Q2 2026 per HSCS's latest filing, from $727026.0 in the prior quarter.
- Over the last five years, Research & Development for HSCS reached as high as $1.4 million in Q2 2022 and fell as low as $434198.0 in Q3 2022.
- A 5-year average of $822388.8 and a median of $757303.0 in 2023 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2023 — Research & Development sank 60.58% — and 2024, when it soared 116.56%.
- Year by year, Research & Development stood at $848976.0 in 2022, then decreased by 10.8% to $757303.0 in 2023, then soared by 58.32% to $1.2 million in 2024, then sank by 39.36% to $727026.0 in 2025, then slumped by 34.5% to $476205.0 in 2026.
- According to Business Quant data, Research & Development over the past three periods registered $476205.0, $727026.0, and $997206.0 for Q2 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 263.30 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 145.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -461.27 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 345.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | HeartSciences | 2.29 Mn | -1.11 Mn | - | 476,205.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 476,205.00 |
| Oct 31, 2025 | 727,026.00 |
| Jul 31, 2025 | 997,206.00 |
| Apr 30, 2025 | 929,091.00 |
| Jan 31, 2025 | 1.03 Mn |
| Oct 31, 2024 | 1.20 Mn |
| Jul 31, 2024 | 1.22 Mn |
| Apr 30, 2024 | 1.05 Mn |
| Jan 31, 2024 | 509,507.00 |
| Oct 31, 2023 | 757,303.00 |
| Jul 31, 2023 | 565,632.00 |
| Apr 30, 2023 | 534,436.00 |
| Jan 31, 2023 | 643,258.00 |
| Oct 31, 2022 | 848,976.00 |
| Jul 31, 2022 | 434,198.00 |
| Apr 30, 2022 | 1.36 Mn |
| Jan 31, 2022 | 699,015.00 |
| Oct 31, 2021 | 545,773.00 |
| Jul 31, 2021 | 401,114.00 |